McCulloch Kevin Insider Trades & Stock Holdings

President and Chief Operating Officer · Xeris Biopharma Holdings, Inc. · Latest filing Oct 1, 2026

McCulloch Kevin, President and Chief Operating Officer at Xeris Biopharma Holdings, Inc. has 2 Form 4 trades on file since Sep 28, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($391.12K), net -$391.12K. Latest filing: disposed of 15K shares of $XERS on Oct 1, 2026 at $9.41.

Trades on file

2

Open-market bought

$0

Open-market sold

$391.12K

Net open-market

-$391.12K

Latest filing

Oct 1, 2026

All insider trades by McCulloch Kevin

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$XERS	Sell (Open-market sale) 10b5-1	15K	$9.41	$141.12K						President and Chief Operating Officer		—
Sep 28, 2026	$XERS	Sell (Open-market sale) 10b5-1	25K	$10	$250K						President and Chief Operating Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks McCulloch Kevin traded

• $XERS

Frequently asked questions

Has McCulloch Kevin been buying or selling stock?

McCulloch Kevin has 0 open-market purchases and 2 open-market sales on file, net -$391.12K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was McCulloch Kevin's latest insider trade?

disposed of 15K shares of $XERS on Oct 1, 2026 at $9.41.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.